Bipolar Disorder Therapeutics Market 2023 : By Size, Share, Growth And Top Companies | AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, GlaxoSmithKline PLC

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per the bipolar disorder therapeutics market report by The Business Research Company, The increase in the prevalence of bipolar disorder is expected to propel the growth of the bipolar disorder therapeutics market going forward. Bipolar disorder refers to a disabling illness that is associated with depressive mood swings and includes symptoms such as irregular sleep, low motivation, and loss of interest in daily activities. Population growth and aging are leading to an increase in the burden of bipolar disorder over time.

The global bipolar disorder therapeutics market size grew from $6.51 billion in 2022 to $6.93 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The bipolar disorder therapeutics market size is expected to grow to $8.36 billion in 2027 at a CAGR of 4.8%.

Read More On The Bipolar Disorder Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Major competitors in the Bipolar Disorder Therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd., and H. Lundbeck A/S.

The Bipolar Disorder Therapeutics market is segmented -
By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs

By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Western Europe was the largest region in the Bipolar Disorder Therapeutics market.

Request A Free Sample Of The Bipolar Disorder Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6736&type=smp

Bipolar disorder therapeutics refer to medication, including mood stabilizers, antidepressants, antipsychotics, and psychological counseling, to control symptoms. The bipolar disorder therapeutic is used in the treatment and management of bipolar disorders.

The Table Of Content For The Bipolar Disorder Therapeutics Market Include:
1. Executive Summary
2. Bipolar Disorder Therapeutics Market Characteristics
3. Bipolar Disorder Therapeutics Market Trends And Strategies
4. Bipolar Disorder Therapeutics Market - Macro Economic Scenario
5. Bipolar Disorder Therapeutics Market Size And Growth
……
26. Africa Bipolar Disorder Therapeutics Market
27. Bipolar Disorder Therapeutics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Bipolar Disorder Therapeutics Market
29. Bipolar Disorder Therapeutics Market Future Outlook and Potential Analysis
30. Appendix

The "Global Bipolar Disorder Therapeutics Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.